Article info
PDFInflammatory bowel disease
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn’s disease and experimental colitis in vivo
- Correspondence to:
Professor A Stallmach
Clinic for Gastroenterology and Hepatology, Catholic Clinics Essen-Nord, D-45329 Essen, Germany; a.stallmachkken.de
Citation
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn’s disease and experimental colitis in vivo
Publication history
- Accepted October 13, 2003
- First published February 11, 2004.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Gut